by José E. Hagan Armed conflict weakens immunization, surveillance, and socioeconomic resilience, increasing measles risk during and after war. Protecting routine vaccination in crises is a core emergency response. In this Perspective, José Hagan discusses how and why weakened immunization, surveillance, and socioeconomic resilience due to armed conflict increases measles risk during and after war, and outlines why protecting routine vaccination in crises should be a core emergency response.
FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 150,000 labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.
AI built on transparent, causal reasoning, systems that ground every output in validated biological mechanisms, show the pathway behind each recommendation, and cite their sources is what makes the difference between a tool that erodes clinical trust and one that rebuilds it. The post Why Generative AI Isn’t Enough: The Case for Causal Reasoning in Medicine appeared first on MedCity News .
It’s not low effort or underinvestment. It’s the steady-state output of an organization succeeding at the wrong thing. The post The Hidden Cost of “Good Enough” in Healthcare Experiences appeared first on MedCity News .
They are vast, deep, and nearly impossible to navigate without the right clinical lens applied on top. The real challenge facing health data platform companies and health system data teams is what to do with all of it. The post Have Healthcare Data Lakes Become “Data Swamps”? appeared first on MedCity News .
The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would help protect the public health of Americans, including youth, by strengthening the agency’s ability to efficiently identify illegal foreign tobacco products — including youth-appealing e-cigarettes — and con
Amid a flurry of traditional IPOs this spring, Talawar Therapeutics is taking a different path to the public markets via a merger with a special purpose acquisition company.
Guidance on the delivery of antenatal screening and selective neonatal immunisation services for pregnant women living with hepatitis B and their babies.
The state’s campaign to end school vaccine requirements is dead for now. The reasons could offer insights into similar efforts’ chances in other states.
The payment by Elevance Health to the Centers for Medicare & Medicaid Services comes as the agency threatened to bar new enrollments in the company’s plans.